![David Gerber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von David Gerber
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Malcisbo AG
![]() Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Gerber
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
University of Zurich | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Swiss Federal Institute of Technology | College/University | Graduate Degree | |
University of Bern | College/University | Corporate Officer/Principal | |
Kein & Aber AG
![]() Kein & Aber AG Publishing: Books/MagazinesConsumer Services Kein & Aber AG engages in publishing books. It publishes books, pocketbooks, electronic books, digital versatile disc's, gift books, and pics and picks. The company was founded by Peter George Haag on June 26, 1992 and is headquartered in Zurich, Switzerland. | Publishing: Books/Magazines | Director/Board Member | |
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Pharmaceuticals: Major | Founder | |
StartAngels Network
![]() StartAngels Network Packaged SoftwareTechnology Services StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland. | Packaged Software | Corporate Officer/Principal | |
Medyria AG
![]() Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | Biotechnology | Director/Board Member |
Statistik
International
Schweiz | 10 |
Vereinigte Staaten | 2 |
Sektoral
Consumer Services | 6 |
Health Technology | 4 |
Finance | 2 |
Technology Services | 2 |
Operativ
Corporate Officer/Principal | 5 |
Founder | 4 |
Director/Board Member | 4 |
Chairman | 3 |
Doctorate Degree | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Bruno Oesch | 6 |
Marc Bär | 6 |
Irene Schiller | 4 |
- Börse
- Insiders
- David Gerber
- Unternehmensverbindungen